$SPCX

Stocks Hit New Highs as Jobs Data Mutes Rate Hike Talk: Stock Market Today

U.S. stocks rose to new highs after July jobs data came in softer than expected, reducing odds of a September FOMC rate hike in federal funds futures to 45% from 55%. The Nasdaq gained 1.3% to 26,690, S&P 500 rose 0.6% to 7,757, and Dow rose 0.3% to 54,036. SpaceX (SPCX) surged 15.8% and Doximity (DOCS) jumped 32.6% on AI-related commentary despite forecast misses.

Original reporting
Published Aug 7, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 9:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Stocks Hit New Highs as Jobs Data Mutes Rate Hike Talk: Stock Market Today — source image
Decision brief

The 30-second read

$SPCXBullishMed
01

Why it matters

Lower short-end yields and reduced hike odds supported equity index highs, while single-stock moves were driven by company-specific catalysts: SPCX’s reversal and DOCS’s AI-focused conference-call reaction.

02

Market read

Traders can use the reduced hike probability and falling yields to manage duration and risk exposure, while monitoring high-volatility single-name setups in SPCX and DOCS into the next macro prints.

03

What to watch

Lock-up expirations for SPCX and the gap between AI messaging and near-term financial delivery for DOCS could cap follow-through.

Relevance 4/10Novelty 4/10Timing: after-hours/next-session positioning ahead of Wednesday CPI and Thursday PPI

Background

The article frames a risk-on session after softer-than-expected July jobs data reduced perceived September FOMC hike odds, while markets look ahead to CPI and PPI.

Company-level read

Ticker impact

$SPCXBullishMedium confidence
Context

SpaceX shares jumped 15.8% on Friday after a prior multi-day slide, with the article citing the end of a four-week losing streak.

Expected impact

Likely choppy upside follow-through near-term, with elevated volatility into upcoming lock-up expirations.

Evidence & confidence

The article provides a same-day catalyst (today’s gain after a losing streak) and a forward risk (additional share supply from lock-up expirations).

$DOCSBullishMedium confidence
Context

Doximity surged 32.6% on Friday, trading far above the prior close despite missing revenue and earnings forecasts.

Expected impact

Potential for continued volatility and momentum, but upside may fade if AI differentiation does not translate into near-term results.

Evidence & confidence

The article ties the move to the conference call, AI tool outperformance claims, and rising usage, while also noting forecast misses.

Market effects

Lower rate-hike odds and falling yields support growth/tech and risk assets broadly; healthcare software can benefit if AI-led narratives catch.

Primarily US market sentiment via Treasury yields and Fed-funds futures; no direct regional-specific catalyst beyond US macro.

WTI weakness tied to Strait of Hormuz negotiations can spill into global energy and inflation expectations, indirectly affecting rates.

Counterpoint

The rally may be fragile because it is driven by macro interpretation (softer labor data) rather than new company fundamentals.

Key entities

  • SpaceX

    SPCX shares rose sharply on Friday after a prolonged losing streak, with lock-up expirations flagged as future supply.

  • Doximity

    DOCS rallied strongly on Friday, with the article attributing the move to AI differentiation discussed on the conference call.

  • US Treasury yields and Fed-funds futures

    2-year and 10-year yields fell, and September hike odds in fed-funds futures declined after the July jobs report.

Related articles

$SPCXMed

SpaceX Stock Drops 10% as Revenue Beats Expectations

SpaceX shares fell about 10% after its first earnings report as a public company, despite a revenue and adjusted-loss beat, according to Reuters and CNBC. SpaceX reported Q2 revenue of $7.81B (vs est. ~$6.93B) and a net loss of $541M. Investors focused on $18.4B quarterly capex, including $15.83B for AI infrastructure, plus potential post-IPO lock-up selling.

$SPCXMed

SPCX Surges 16%: Lockup Expiration Passes Cleanly

SpaceX (NASDAQ: SPCX) rose 15.8% on Aug. 7, closing at $133.11 after its first post-IPO lockup expiration on Aug. 6 passed without a broad insider selloff. The move followed Q2 results on Aug. 4, when revenue rose 92% to $7.81B. Next unlocks are Aug. 20 and late September.

$DOCSHighAI 9/10

A Lesser-Known Stock Climbed More Than 100% In a Day After AI Surprise. Here’s Why.

Doximity (DXRX) shares jumped after the company reported fiscal Q1 2027 results and said its new AI search product is generating strong unit economics. CEO Jeffrey Tangney said revenue is over 10 times per search versus cost. Q1 revenue was $156.6M and adjusted EBITDA $74.8M. Full-year revenue guidance raised to $671M-$681M; short interest was about 17%, contributing to a short squeeze.

$SPCXMed

Top Analyst Drops Sharp Take on SpaceX Stock

Argus Research upgraded newly public SpaceX (NASDAQ:SPCX) to Buy from Hold and set a $160 price target. The firm cited Q2 results with revenue up 92% to $7.8B versus $6.93B consensus and a $541M loss, better than expected. Argus expects revenue near $110B in 2027, supporting a ~20x projected-sales valuation amid concerns over rising AI infrastructure spending and share unlocks.